Asia Pacific Glucose Monitoring System (Cgms & Smbg) Market Forecast 2017-2025KEY FINDINGS
Asia-Pacific CGMS Market is growing at a CAGR of 48.72% and the SMBG Market is anticipated to hit $1544 million in the year 2025 with 11.22% of CAGR. The deliberated base year for the market analysis is 2016 and the forecasting period of the glucose monitoring system market is 2017-2025. The diverse factors leading to the GMS market are an augmented increase in the number of people suffering from diabetes, authorization of artificial pancreas, greater awareness, and improved healthcare infrastructure and ease of using CGMS devices.
The glucose monitoring system market is bifurcated into continuous glucose monitoring system and self-monitoring of blood glucose.The CGMS market is segmented by application, component type. There are diverse component types that include the transmitters and receivers, and the sensors. The Sensors are further segmented on the basis of holter type retrospective sensors, insulin pumps, noninvasive glucose sensors, minimally invasive glucose sensors and real-time sensors. The glucose monitors applications include homes, hospitals, diagnostics, and clinics. The SMBG market is segmented into component type, application. The component type market comprises of test strips, glucose meter, and others. The market by application is divided into home settings, hospitals, and clinics. High costing of continuous glucose monitoring systems, deficient reimbursement options, and stringent regulatory norms are the factors that are likely to restrain the market growth. The countries mentioned in the GMS Asia-Pacific market are India, China, Australia and rest of the Asia-Pacific.
Major giants of the GMS market are Insulet Corporation, Medtronic Inc, Abbott Laboratories, Glysens Inc., Bayer AG Roche, Animas Corporation, Dexcom Inc., Novo Nordisk, and Ypsomed AG.